Search the Site

EXAS - Playing the Validation Results

publication date: Oct 27, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
With the Exact Sciences data validation results quickly approaching it is apparent that traders are a bit jumpy.  This morning share price jumped to $9.19 before quickly falling to $8.20.  There is obviously some volatility remaining in EXAS.  Lets look at one way to try and profit from tomorrow's data release....


Sorry this page is available to subscribers only. If you're not a subscriber why not join today?

If you are already a subscriber, please login.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site including:

- Detailed Reports on Upcoming FDA / Clinical Trades
- Analyst Reports with consistently updated summaries
- Run-Up Valuation Studies
- Gameplan Videos
- Live Chat
- Weekly Newsletter
- Email / SMS (Text Message) Alerts of critical news
- BioRunUp's and Mike Havrilla's Trading Accounts
- BioRunUp Forums
- A More Detailed FDA Calendar
- Increased Organization of Tracking Upcoming Catalysts
- A Unique Ratings System to Grade Catalysts
- A Growing Focus on Upcoming Clinical Trial Catalysts
- Direct Email Communication
- Affiliate Program, earn $50 for every referral who joins

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site including:

- Detailed Reports on Upcoming FDA / Clinical Trades
- Analyst Reports with consistently updated summaries
- Run-Up Valuation Studies
- Gameplan Videos
- Live Chat
- Weekly Newsletter
- Email / SMS (Text Message) Alerts of critical news
- BioRunUp's and Mike Havrilla's Trading Accounts
- BioRunUp Forums
- A More Detailed FDA Calendar
- Increased Organization of Tracking Upcoming Catalysts
- A Unique Ratings System to Grade Catalysts
- A Growing Focus on Upcoming Clinical Trial Catalysts
- Direct Email Communication
- Affiliate Program, earn $50 for every referral who joins